Method for treating secondary hyperparathyroidism in CKD
US9925147B2 · kind B2 · utility
0Cited by
105References
98Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 21, 2016 |
| Grant date | Mar 27, 2018 |
| Priority date | — |
| Expiry date | Dec 9, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0019
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A stable, controlled release formulation for oral dosing of vitamin D compounds is disclosed. The formulation is prepared by incorporating one or more vitamin D compounds into a solid or semi-solid mixture of waxy materials. Oral dosage forms can be prepared by melt-blending the components described herein and filling gelatin capsules with the formulation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.